PathAI, Inc.
Funding rounds
2 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Apr 2019 | $60 M | No. 2 | $50 to $250 million | equity | SEC | |
| Oct 2017 | $15 M | No. 1 | $10 to $50 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
PathAI, Inc. chose not to state its revenue in its newest notice of a funding round (Apr 2019).
SEC Form D · Apr 2019
The industry group it chose in its notices: Biotechnology.
SEC Form D · Apr 2019
That is all the official record says: PathAI, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
In its own words
How the company describes itself to search engines on its website, word for word.
“At PathAI, we’re dedicated to improving patient outcomes with AI-powered pathology and meaningful collaboration with biopharma, laboratories and clinicians.”
Source: The company's website · as of Nov 15, 2026
Products and services#
No products or services on record: its website does not describe any in structured form (a page that declares itself a product or service), and Wikidata lists none.
Investors#
No investor of PathAI, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 23 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Aditya Khosla | Executive officer | Apr 2019 |
| Andrew Beck | Executive officer | Apr 2019 |
| Aditya Khosla | Director | Apr 2019 |
| Andrew Beck | Director | Apr 2019 |
| Jeff Leiden | Director | Apr 2019 |
| Michelle Dipp | Director | Apr 2019 |
| Stanley Lapidus | Director | Apr 2019 |
About
Company in Brookline, United States.